Holen Sie sich die Stockscreener-App
1.77
4.84%
-0.09
Handel nachbörslich:
1.70
-0.07
-3.95%
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
7.04%
7.3779
|
7.9365 | 7.3125 | 6.3084 | 6.6541 |
| Costs And Expenses |
4.35%
12.00
|
12.55 | 9.4135 | 8.294 | 8.7053 |
| Operating Income/Loss |
4.35%
-12.00
|
-12.55 | -9.4135 | -8.294 | -8.7053 |
| Nonoperating Income/Loss |
290.11%
-9.5802
|
5.0392 | -4.3189 | 0.0728 | 0.124 |
| Income/Loss From Continuing Operations Before Tax |
3.19%
-12.00
|
-11.63 | -9.4135 | -8.2212 | -8.5813 |
| Income/Loss From Continuing Operations After Tax |
189.74%
-21.58
|
-7.4487 | -13.73 | -8.2212 | -8.5813 |
Net Income/Loss
|
189.74%
-21.58
|
-7.4487 | -13.73 | -8.2212 | -8.5813 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,008%
29.35
|
0.9443 | 11.31 | 11.26 | 11.26 |
| Diluted Average Shares |
3,008%
29.35
|
0.9443 | 11.31 | 11.26 | 11.26 |
| Basic Earnings Per Share |
85.00%
-0.74
|
-0.40 | -1.21 | -0.73 | -0.76 |
| Diluted Earnings Per Share |
85.00%
-0.74
|
-0.40 | -1.21 | -0.73 | -0.76 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):